Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon Meta IMD Test

Metabolon has launched Meta IMD through its CLIA laboratory-developed test. The test identifies hundreds of metabolites associated with a wide range of inherited metabolic disorders — including developmental delay, seizures, low blood sugar, or speech and/or language delay — from a small plasma sample. A 250 microliter plasma sample provides specific information to assist the physician in deciding what additional clinical tests are needed to confirm or clarify a diagnosis, the company said. Results are typically delivered in about 21 days.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.